QSS
APLS

Quantitative Systematic Strategies’s Apellis Pharmaceuticals APLS Stock Holding History

Quantitative Systematic Strategies’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,543
Closed -$281K – 466
2021
Q1 		$281K Sell
6,543
-7,626
-54% -$361K 0.04% 481
2020
Q4 		$810K Buy
14,169
+6,615
+88% +$280K 0.11% 285
2020
Q3 		$228K Buy
+7,554
New +$226K 0.04% 495
2020
Q1 		– Sell
-11,449
Closed -$351K – 262
2019
Q4 		$351K Buy
+11,449
New +$317K 0.05% 411
2018
Q1 		– Sell
-14,586
Closed -$317K – 620
2017
Q4 		$317K Buy
+14,586
New +$215K 0.08% 370

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Quantitative Systematic Strategies's APLS Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Apellis Pharmaceuticals (APLS) in Q2 2021, closing a stake of 6,543 shares — an estimated $281K sold.

Quantitative Systematic Strategies first reported a position in APLS in Q4 2017 and held it in 5 quarters. The position peaked at $810K in Q4 2020. 204 funds tracked by Wall St. Rank hold APLS as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Apellis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 6,543 Apellis Pharmaceuticals shares in Q2 2021, an estimated $281K.
  • Quantitative Systematic Strategies first reported a position in Apellis Pharmaceuticals in Q4 2017 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Apellis Pharmaceuticals position peaked at $810K in Q4 2020.
  • 204 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.